Cancer Cachexia Clinic and Research Integration Program (CaXI)

Our team of basic and clinical researchers will work together to better understand the molecular mechanisms of cancer cachexia, develop new methods for earlier-detection and improve clinical treatments

Cancer cachexia is a cancer-induced wasting syndrome which affects 30% of all cancer patients and 80% of patients with advanced cancers.

It is different from malnutrition as it cannot be reversed by increasing calorie intake. As it progresses, patients with cancer cachexia experience reduced quality of life and physical performance, and lower response to and tolerance of cancer treatments.

This initiative - the Cancer CacheXia Clinic and Research Integration Program (CaXI) - aims to increase understanding of cancer cachexia and improve outcomes for patients.



Announcing a half-day workshop (available via Zoom) on Cancer Cachexia where colleagues from Charite Berlin, Helmholtz Munich, and Melbourne will be talking about cachexia, latest research, diagnosis and treatment, and to foster the collaboration between UKBonn and other national and international institutes.

To find out more, see Exploring the Intersection of Radiology Imaging and Immunology in Cancer Cachexia poster.

Meet the team


E: This email address is being protected from spambots. You need JavaScript enabled to view it.